Calix Increases Stock Repurchase Authorization by An Additional $125 Million

Calix, Inc. (NYSE: CALX,OTC:CLXLF) today announced that its board of directors increased the authorization to repurchase the Company's common stock by an additional $125 million under the existing stock repurchase program. The additional authorization announced today will be added to the remaining common stock repurchase authorization which totaled $109.3 million at the end of the fourth quarter of 2025.

Under the repurchase program, repurchases can be made from time to time using a variety of methods, which may include open market purchases, privately negotiated transactions or otherwise, all in accordance with the rules of the Securities and Exchange Commission and other applicable legal requirements. The specific timing, price and size of the purchases will depend on prevailing stock prices, general economic and market conditions, and other considerations consistent with the Company's capital allocation strategy. The stock repurchase program does not obligate Calix to purchase any dollar amount or number of shares of common stock and the program may be suspended or discontinued at any time.

About Calix

Calix, Inc . (NYSE: CALX,OTC:CLXLF) Calix delivers the industry's leading agentic AI cloud and appliance-based platform, purpose-built over two decades with open standards and advanced security so service providers of all types and sizes can transform into experience providers. The platform combines agentic AI, intelligent appliances, and fully integrated managed services with Calix Success and a partner community to simplify operations, engagement, and service, innovate for their consumer, business, and municipal subscribers, and grow their value for members, investors, and the communities they serve.

Forward-Looking Statements

This press release contains forward-looking statements that are based upon management's current expectations and are inherently uncertain. Forward-looking statements relate to, but are not limited to, Calix's stock repurchase program, are based upon information available to us as of the date of this release, and we assume no obligation to revise or update any such forward-looking statement to reflect any event or circumstance after the date of this release, except as required by law. Actual results and the timing of events could differ materially from current expectations based on risks and uncertainties affecting Calix's business. The reader is cautioned not to rely on the forward-looking statements contained in this press release. Additional information on potential factors that could affect Calix's results and other risks and uncertainties are detailed in its quarterly reports on Form 10-Q and Annual Report on Form 10-K filed with the SEC and available at www.sec.gov .

Category: Financial

Investor Inquiries:
Nancy Fazioli
VP, Investor Relations
InvestorRelations@calix.com
(669) 308 3901

News Provided by Business Wire via QuoteMedia

CALX
The Conversation (0)

Alexion Reports Fourth Quarter and Full Year 2019 Results

Alexion Pharmaceuticals (NASDAQ:ALXN) announced financial results for the fourth quarter and full year of 2019. As quoted in the press release: Total revenues for the full year of 2019 were $4,991.1 million, a 21 percent increase compared to 2018. The negative impact of foreign currency on total... Keep Reading...

Alexion Confirms Planned Phase 3 Study of ALS Treatment

Alexion (NASDAQ:ALXN) announced that is plans to start a Phase 3 study of ULTOMIRIS (ravulizumab) in amyotrophic lateral sclerosis (ALS). As quoted in the press release: The 50-week global study, called CHAMPION-ALS, will evaluate approximately 350 adults across a broad patient population, and... Keep Reading...
Mockup of person with brain chip like the one Neuralink is creating.

Can You Invest in Neuralink?

Elon Musk's Neuralink has captured the public’s attention and imagination with its futuristic vision of connecting the human brain to computers.Neuralink has drawn interest to the brain computer interface (BCI) sector with its N1 implant, which is undergoing human trials in patients with spinal... Keep Reading...
Laptop with overlay of fluctuating financial graphs and data points.

Tech Weekly: Mega-cap Earnings Dominate Narrow Trading Week

Welcome to the Investing News Network's weekly brief on tech news and tech stocks driving the market. We also break down next week's catalysts to watch to help you prepare for the week ahead.Don't forget to follow us @INN_Technology for real-time news updates!Securities Disclosure: I, Meagen... Keep Reading...
Quarterly Activities/Appendix 4C Cash Flow Report

Quarterly Activities/Appendix 4C Cash Flow Report

RocketBoots (ROC:AU) has announced Quarterly Activities/Appendix 4C Cash Flow ReportDownload the PDF here. Keep Reading...
Q2 FY2026 Quarterly Activities and Cash Flow Report

Q2 FY2026 Quarterly Activities and Cash Flow Report

RemSense Technologies (REM:AU) has announced Q2 FY2026 Quarterly Activities and Cash Flow ReportDownload the PDF here. Keep Reading...
Colorful financial chart with trends, showing candles and moving averages on a dark background.

Tech Weekly: Tech Stocks Tumble on Intel's Guidance Gap

Welcome to the Investing News Network's weekly brief on tech news and tech stocks driving the market. We also break down next week's catalysts to watch to help you prepare for the week ahead.Don't forget to follow us @INN_Technology for real-time news updates!Securities Disclosure: I, Meagen... Keep Reading...
Syntheia Signs Non-Binding LOI for SATCOM Acquisition

Syntheia Signs Non-Binding LOI for SATCOM Acquisition

Syntheia Corp. (CSE: SYAI,OTC:SYAIF) ("Syntheia" or the "Company") (Syntheia.ai), a leading provider of conversational AI solutions for inbound telephone call management, is pleased to announce that it has entered into a non-binding letter of intent (the "LOI"), dated January 12, 2026, with CX1... Keep Reading...

Interactive Chart

Latest Press Releases

Related News